Excessive Toxicity After Treatment of Congenital Acute Myeloid Leukemia

Klin Padiatr. 2019 Nov;231(6):291-293. doi: 10.1055/a-0859-7375. Epub 2019 Mar 18.

Authors

Pascal Johann^{1

2}, Martin Thomas Dabek³, Tina Heinzmann⁴, Jens Westhoff⁵, Andreas Kulozik², Joachim Kunz²

Affiliations

¹ German Cancer Research Center, Division of Pediatric Neurooncology, Heidelberg.
² Department of Pediatric Hematology, Oncology and Immunology, Children's Hospital, UniversitatsKlinikum Heidelberg, Heidelberg.
³ Department of Neonatology, University Hospital Bern.
⁴ Klinik für Neonatologie, Universitätsklinikum Heidelberg, Heidelberg.
⁵ Department of Pediatrics I, University Hospital Heidelberg, Heidelberg.

PMID: 30887493
DOI: 10.1055/a-0859-7375

No abstract available

Publication types

Case Reports
Review

MeSH terms

Antimetabolites, Antineoplastic / administration & dosage
Antimetabolites, Antineoplastic / toxicity*
Cytarabine / administration & dosage
Cytarabine / toxicity*
Humans
Infant
Leukemia, Myeloid, Acute / drug therapy*

Substances

Antimetabolites, Antineoplastic
Cytarabine